These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2227754)

  • 1. [Improvement in diabetes therapy. Interview by Heike E. Nähtke].
    Mehnert H
    Fortschr Med; 1990 Sep; 108(27):72, 75. PubMed ID: 2227754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle].
    Drent ML; van der Veen EA
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):308-10. PubMed ID: 1538796
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR; Lembcke B
    Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561
    [No Abstract]   [Full Text] [Related]  

  • 4. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA
    Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
    [No Abstract]   [Full Text] [Related]  

  • 5. [New, in Austria registered specialty drugs. Glucobay (acarbose)].
    Sturm M
    Wien Klin Wochenschr; 1992; 104(11):329-36. PubMed ID: 1621396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of acarbose on intestinal disaccharidase: review of its therapeutic potential].
    Sternberg A; Wagner Y; Fireman Z
    Harefuah; 1994 May; 126(9):527-9. PubMed ID: 8034269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acarbose].
    Nakano K
    Nihon Rinsho; 1997 Nov; 55 Suppl():120-4. PubMed ID: 9434454
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
    Hayakawa T; Noda A; Kondo T; Okumura N
    Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
    [No Abstract]   [Full Text] [Related]  

  • 9. Acarbose for diabetes mellitus.
    Med Lett Drugs Ther; 1996 Feb; 38(967):9-10. PubMed ID: 8559114
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-glucosidase inhibitors in diabetes. Introduction.
    Kruseman AC; Sels JP; Wolffenbuttel BH
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():1. PubMed ID: 8001619
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of acarbose in the treatment of diabetes mellitus].
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):385-90. PubMed ID: 9805654
    [No Abstract]   [Full Text] [Related]  

  • 14. alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
    Dimitriadis G; Raptis S
    Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the safety and efficacy of acarbose in diabetes mellitus.
    Yee HS; Fong NT
    Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acarbose in the treatment of type 2 diabetes].
    Amoretti R; Cicconetti C; De Nichilo M; Teodonio C; Fasani R; Carosi M
    Minerva Dietol Gastroenterol; 1986; 32(1):53-9. PubMed ID: 3517699
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F
    Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer hypoglycaemic agents-its relevance.
    Shah SN; Ajmera J
    J Assoc Physicians India; 1993 Nov; 41(11):699. PubMed ID: 8005919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.